Skip survey header

2019 Severe Asthma Registration

This activity will delve into the lives of US Presidents with asthma, to draw a contrast between treatment approaches of the past and current and emerging therapies that target specific disease mechanisms. We’ll summarize mechanisms of action as well as key efficacy and safety data for cytokine antagonists being used or investigated for severe asthma treatment. The information learned will then be applied, using case scenarios, in selecting personalized treatments based on asthma phenotypes and endotypes. MORE INFO (Agenda, Faculty and Learning Objectives)
This question requires a valid email address.
2. By checking this box, you consent to receiving up to SMS or MMS informational about your upcoming ATS 2019 symposium on May 21st. Message and data rates may apply. To opt out of the text messaging program, send the word STOP at any time. *This question is required.
An MECC-Organized Symposia at the ATS 2019 International Conference. All ATS 2019 International Conference attendees are invited to attend this Non-CME educational program sponsored by The France Foundation and supported by a grant from Sanofi Genzyme and Regeneron Pharmaceuticals